Announcement PDF VENARI MINERALS NL (FORMERLY KNOWN AS ASTUTE METALS NL) ACN 007 090 904 NOTICE OF ANNUAL GENERAL MEETING Notice is given that the Meeting will be held at: TIME: 10:30am (AEDT) DATE: 21 November 2025 PLACE: Offices of Venari Minerals NL Suite 116, Level 1, 165 - 167 to Phillip Street SYDNEY NSW 2000 The business of the Meeting affects your shareholding and your vote is important. This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 7:00pm AEDT on 19 November 2025. 5955-01/3781790_10 1 BUSINESS OF THE MEETING AGENDA 1. FINANCIAL STATEMENTS AND REPORTS To receive and consider the annual financial report of the Company for the financial year ended 30 June 2025 together with the declaration of the Directors, the Director’s report, the Remuneration Report and the auditor’s report. 2. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT To consider and, if thought fit, to pass, with or without amendment, the following resolution as a non-binding resolution: “That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as contained in the Company’s annual financial report for the financial year ended 30 June 2025.” Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company. 3. RESOLUTION 2 – ELECTION OF A DIRECTOR – VINCENT FAYAD To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution: “That, for the purpose of clause 12.2 of the Constitution, Listing Rule 14.5 and for all other purposes, Vincent Fayad, a Director, retires by rotation, and being eligible, is re-elected as a Director.” 4. RESOLUTION 3 – APPROVAL OF 7.1A MANDATE To consider and, if thought fit, to pass the following resolution as a special resolution: “That, for the purposes of Listing Rule 7.1A and for all other purposes, approval is given for the Company to issue up to that number of Equity Securities equal to 10% of the issued capital of the Company at the time of issue, calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and otherwise on the terms and conditions set out in the Explanatory Statement.” 5. RESOLUTION 4 – CONSOLIDATION OF CAPITAL To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution: "That, pursuant to section 254H of the Corporations Act and for all other purposes, Shareholders approve the consolidation of the issued capital of the Company on the basis that: (a) every 10 Shares be consolidated into 1 Share; (b) every 10 Options be consolidated into 1 Option; and (c) every 10 Performance Rights be consolidated into 1 Performance Right, with fractional entitlements rounded down to the nearest whole Security." Dated: 22 October 2025 5955-01/3781790_10 2 Voting Prohibition Statements Resolution 1 – Adoption of Remuneration Report A vote on this Resolution must not be cast (in any capacity) by or on behalf of either of the following persons: (a) a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report; or (b) a Closely Related Party of such a member. However, a person (the voter) described above may cast a vote on this Resolution as a proxy if the vote is not cast on behalf of a person described above and either: (a) the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or (b) the voter is the Chair and the appointment of the Chair as proxy: (i) does not specify the way the proxy is to vote on this Resolution; and (ii) expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel. However, this does not apply to a vote cast in favour of the Resolution by: (a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way. 5955-01/3781790_10 3 Voting by proxy To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form. In accordance with section 249L of the Corporations Act, Shareholders are advised that: • each Shareholder has a right to appoint a proxy; • the proxy need not be a Shareholder of the Company; and • a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints two proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes. Shareholders and their proxies should be aware that: • if proxy holders vote, they must cast all directed proxies as directed; and • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed. Voting in person To vote in person, attend the Meeting at the time, date and place set out above. Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company Secretary on +61 2 8046 2799. 5955-01/3781790_10 4 E X PL A N A T O R Y S T A T E M E N T This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions. 1. FINANCIAL STATEMENTS AND REPORTS In accordance with the Corporations Act, the business of the Meeting will include receipt and consideration of the annual financial report of the Company for the financial year ended 30 June 2025 together with the declaration of the Directors, the Directors’ report, the Remuneration Report and the auditor’s report. The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless specifically requested to do so. The Company’s annual financial report is available on its website at www.venariminerals.com. 2. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT 2.1 General The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the remuneration report to be adopted must be put to the shareholders. However, such a resolution is advisory only and does not bind the company or the directors of the company. The remuneration report sets out the company’s remuneration arrangements for the directors and senior management of the company. The remuneration report is part of the directors’ report contained in the annual financial report of the company for a financial year. The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or make comments on the remuneration report at the annual general meeting. 2.2 Voting consequences A company is required to put to its shareholders a resolution proposing the calling of another meeting of shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general meetings. If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder meeting (Spill Meeting) within 90 days of the second annual general meeting. All of the directors of the company who were in office when the directors' report (as included in the company’s annual financial report for the most recent financial year) was approved, other than the managing director of the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting. Following the Spill Meeting those persons whose election or re-election as directors of the company is approved will be the directors of the company. 2.3 Previous voting results At the Company’s previous annual general meeting the votes cast against the remuneration report considered at that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not relevant for this Meeting. 5955-01/3781790_10 5 3. RESOLUTION 2 – ELECTION OF A DIRECTOR – VINCENT FAYAD 3.1 General Listing Rule 14.5 provides that an entity which has directors must hold an election of directors at each annual general meeting. The Constitution sets out the requirements for determining which Directors are to retire by rotation at an annual general meeting. Vincent Fayad, who has held office without re-election since 22 November 2023 and being eligible retires by rotation and seeks re-election. Further information in relation to Mr Fayad is set out below. Qualifications, experience and other material directorships Mr Fayad is a Chartered Accountant with over 40 years’ experience in management, mergers and acquisitions, and debt and equity transactions in various sectors including mining and exploration. He is an experienced former Director, Chairman and advisor to a number of listed companies, including various resources companies. Term of office Mr Fayad has served as a Director of the Company since 10 October 2017. Independence If re-elected and having considered the role and responsibilities of Mr Fayad in relation to the Company in accordance with the guidelines of the ASX Corporate Governance Council, the Board considers Mr Fayad not to be an independent Director of the Company. Other material information The Company conducts appropriate checks on the background and experience of candidates before their appointment to the Board. These include checks as to a person’s experience, educational qualifications, and criminal record The Company undertook such checks prior to the appointment of Mr Healy. Board recommendation Having received an acknowledgement from Mr Fayad that he will have sufficient time to fulfil their responsibilities as a Director and having reviewed the performance of Mr Fayad since his appointment to the Board and the skills, knowledge, experience and capabilites required by the Board, the Directors (other than Mr Fayad) recommend that Shareholders vote in favour of this Resolution. 3.2 Technical information required by Listing Rule 14.1A If this Resolution is passed, Mr Fayad will be re-elected to the Board as non-executive Director of the Company. If this Resolution is not passed, Mr Fayad will not continue in their role as non-executive Director. The Company will begin to seek nominations or otherwise identify suitably qualified candidates to join the Company to replace Mr Fayad. As an additional consequence, this may detract from the Board and Company’s ability to execute on its strategic vision. 4. RESOLUTION 3 – APPROVAL OF 7.1A MANDATE 4.1 General This Resolution seeks Shareholder approval by way of special resolution for the Company to have the additional 10% placement capacity provided for in Listing Rule 7.1A to issue Equity Securities without Shareholder approval. Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start of that period. 5955-01/3781790_10 6 Under Listing Rule 7.1A, an Eligible Entity may seek shareholder approval by way of a special resolution passed at its annual general meeting to increase this 15% limit by an extra 10% to 25% (7.1A Mandate). An Eligible Entity means an entity which is not included in the S&P/ASX 300 Index and has a market capitalisation of $300,000,000 or less. As of the date of this Notice, the Company’s market capitalisation is $19.02 million. The Company is therefore an Eligible Entity. 4.2 Technical information required by Listing Rule 14.1A For this Resolution to be passed, at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting must be cast in favour of the Resolution. If this Resolution is passed, the Company will be able to issue Equity Securities up to the combined 25% limit in Listing Rules 7.1 and 7.1A without any further Shareholder approval. If this Resolution is not passed, the Company will not be able to access the additional 10% capacity to issue Equity Securities without Shareholder approval under Listing Rule 7.1A and will remain subject to the 15% limit on issuing Equity Securities without Shareholder approval set out in Listing Rule 7.1. 4.3 Technical information required by Listing Rule 7.3A REQUIRED INFORMATION DETAILS Period for which the 7.1A Mandate is valid The 7.1A Mandate will commence on the date of the Meeting and expire on the first to occur of the following: (a) the date that is 12 months after the date of this Meeting; (b) the time and date of the Company’s next annual general meeting; and (c) the time and date of approval by Shareholders of any transaction under Listing Rule 11.1.2 (a significant change in the nature or scale of activities) or Listing Rule 11.2 (disposal of the main undertaking). Minimum price Any Equity Securities issued under the 7.1A Mandate must be in an existing quoted class of Equity Securities and be issued for cash consideration at a minimum price of 75% of the volume weighted average price of Equity Securities in that class, calculated over the 15 trading days on which trades in that class were recorded immediately before: (a) the date on which the price at which the Equity Securities are to be issued is agreed by the entity and the recipient of the Equity Securities; or (b) if the Equity Securities are not issued within 10 trading days of the date in paragraph (a) above, the date on which the Equity Securities are issued. Use of funds The Company intends to use funds raised from issues of Equity Securities under the 7.1A Mandate for the continued exploration expenditure on the Company’s mining projects, in particular, the Needles Gold, Georgina Basin and Red Mountain Projects, the review of technologies for the processing of the Company’s mineral sands projects, acquisition of new assets and investments (including expenses associated with such an acquisition) and general working capital. Risk of economic and voting dilution Any issue of Equity Securities under the 7.1A Mandate will dilute the interests of Shareholders who do not receive any Shares under the issue. If this Resolution is approved by Shareholders and the Company issues the maximum number of Equity Securities available under 5955-01/3781790_10 7 REQUIRED INFORMATION DETAILS the 7.1A Mandate, the economic and voting dilution of existing Shares would be as shown in the table below. The table below shows the dilution of existing Shareholders calculated in accordance with the formula outlined in Listing Rule 7.1A.2, on the basis of the closing market price of Shares and the number of Equity Securities on issue and proposed to be issued as at 17 October 2025. The table also shows the voting dilution impact where the number of Shares on issue (Variable A in the formula) changes and the economic dilution where there are changes in the issue price of Shares issued under the 7.1A Mandate. DILUTION Number of Shares on Issue (Variable A in Listing Rule 7.1A.2) Shares issued – 10% voting dilution Issue Price $0.009 $0.018 $0.027 50% decrease Issue Price 50% increase Funds Raised Current 1,056,816,363 Shares 105,681,636 Shares $951,134 $1,902,269 $2,853,404 50% increase 1,585,224,545 Shares 158,522,454 Shares $1,426,702 $2,853,404 $4,280,106 100% increase 2,113,632,726 Shares 211,363,272 Shares $1,902,269 $3,804,538 $5,706,808 *The number of Shares on issue (Variable A in the formula) could increase as a result of the issue of Shares that do not require Shareholder approval (such as under a pro-rata rights issue or scrip issued under a takeover offer) or that are issued with Shareholder approval under Listing Rule 7.1. The table above uses the following assumptions: 1. There are currently 1,056,816,363 Shares on issue as at the date of this Notice. 2. The issue price set out above is the closing market price of the Shares on the ASX on 17 October 2025 (being $0.018). 3. The Company issues the maximum possible number of Equity Securities under the 7.1A Mandate. 4. The Company has not issued any Equity Securities in the 12 months prior to the Meeting that were not issued under an exception in Listing Rule 7.2 or with approval under Listing Rule 7.1. 5. The issue of Equity Securities under the 7.1A Mandate consists only of Shares. It is assumed that no Options are exercised into Shares before the date of issue of the Equity Securities. If the issue of Equity Securities includes quoted Options, it is assumed that those quoted Options are exercised into Shares for the purpose of calculating the voting dilution effect on existing Shareholders. 6. The calculations above do not show the dilution that any one particular Shareholder will be subject to. All Shareholders should consider the dilution caused to their own shareholding depending on their specific circumstances. 7. This table does not set out any dilution pursuant to approvals under Listing Rule 7.1 unless otherwise disclosed. 8. The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital at the time of issue. This is why the voting dilution is shown in each example as 10%. 9. The table does not show an example of dilution that may be caused to a particular Shareholder by reason of placements under the 7.1A Mandate, based on that Shareholder’s holding at the date of the Meeting. 5955-01/3781790_10 8 REQUIRED INFORMATION DETAILS Shareholders should note that there is a risk that: (a) the market price for the Company’s Shares may be significantly lower on the issue date than on the date of the Meeting; and (b) the Shares may be issued at a price that is at a discount to the market price for those Shares on the date of issue. Allocation policy under 7.1A Mandate The recipients of the Equity Securities to be issued under the 7.1A Mandate have not yet been determined. However, the recipients of Equity Securities could consist of current Shareholders or new investors (or both), none of whom will be related parties of the Company. The Company will determine the recipients at the time of the issue under the 7.1A Mandate, having regard to the following factors: (a) the purpose of the issue; (b) alternative methods for raising funds available to the Company at that time, including, but not limited to, an entitlement issue, share purchase plan, placement or other offer where existing Shareholders may participate; (c) the effect of the issue of the Equity Securities on the control of the Company; (d) the circumstances of the Company, including, but not limited to, the financial position and solvency of the Company; (e) prevailing market conditions; and (f) advice from corporate, financial and broking advisers (if applicable). Previous approval under Listing Rule 7.1A.2 The Company previously obtained approval from its Shareholders pursuant to Listing Rule 7.1A at its annual general meeting held on 15 November 2024 (Previous Approval). During the 12 month period preceding the date of the Meeting, being on and from [21] November 2024, the Company has not issued any Equity Securities pursuant to the Previous Approval. Voting exclusion statement As at the date of this Notice, the Company is not proposing to make an issue of Equity Securities under Listing Rule 7.1A. Accordingly, a voting exclusion statement is not included in this Notice. 5. RESOLUTION 4 – CONSOLIDATION OF CAPITAL 5.1 Background This Resolution seeks Shareholder approval for the purposes of section 254 of the Corporations Act and all other purposes to consolidate the Company's issued capital on a 10:1 basis (Consolidation). 5.2 Legal requirements Section 254H of the Corporations Act provides that a company may, by resolution passed in a general meeting, convert all or any of its shares into a larger or smaller number. Listing Rule 7.20 provides that if an entity proposes to reorganise its capital, it must tell shareholders of each of the following: (a) the effect of the proposal on the number of securities and the amount unpaid (if any) of the securities; 5955-01/3781790_10 9 (b) the proposed treatment of any fractional entitlements arising from the reorganisation; and (c) the proposed treatment of any convertible securities on issue. Listing Rule 7.21 provides that an entity which has convertible securities (except options) on issue may only reorganise its capital if, in respect of the convertible securities, the number of securities or the conversion price, or both, is reorganised so that the holder of the convertible securities will not receive a benefit that holders of ordinary securities do not receive. Listing Rule 7.22 provides that where an entity with options on issue undertakes a consolidation of its issued capital, the number of options must be consolidated in the same ratio as the ordinary capital and the exercise price must be amended in inverse proportion to that ratio. 5.3 Effect on capital structure The effect which the Consolidation will have on the Company’s capital structure is set out in the table below. SHARES OPTIONS1 PERFORMANCE RIGHTS1 Pre-Consolidation Securities on issue as at the date of the Meeting 1,056,816,363 321,847,282 45,977,500 Post-Consolidation Securities on issue following the date of the Meeting2,3 105,681,636 32,184,728 4,597,750 Notes: 1. The terms of these Options and Performance Rights are set out in the table below. 2. Assumes no Shares are issued (including on the exercise or conversion of convertible securities). 3. Subject to rounding of fractional entitlements in accordance Section 5.4 below. The effect the Consolidation will have on the terms of the convertible securities that are current only issue (subject to rounding of fractional entitlements) is set out in the tables below: Quoted Options CLASS EXPIRY DATE PRE-CONSOLIDATION POST-CONSOLIDATION NUMBER EXERCISE PRICE NUMBER EXERCISE PRICE ASEO 21 August 2026 291,847,282 $0.05 29,184,728 $0.50 ASEAU 26 September 2028 30,000,000 $0.03 3,000,000 $0.30 Performance Rights CLASS / TRANCHE PRE-CONSOLIDATION POST-CONSOLIDATION ASEAA 9,530,000 953,000 ASEAB 9,530,000 953,000 ASEAC 9,530,000 953,000 ASEAD 9,530,000 953,000 ASEAS 7,857,500 785,750 Total 45,977,500 4,597,750 5955-01/3781790_10 10 Certain Performance Rights, which are currently on issue, will vest and be capable of being exercisable into Shares upon the volume weighted average price of Shares calculated over a prescribed period exceeding particular prices prior to the expiry date. Further information in relation to the impact of the Consolidation on these Performance Rights is set out in the table below. CLASS EXPIRY DATE VWAP CALCULATION PERIOD PRE-CONSOLIDATION POST-CONSOLIDATION NUMBER VWAP MILESTONE NUMBER VWAP MILESTONE ASEAA 36 months from the date of issue of the Performance Rights. Calculated over a consecutive 20 day period prior to the expiry date. 9,530,000 Where the Company’s Share price reaches a volume weighted average price of $0.08 per Share. 953,000 Where the Company’s Share price reaches a volume weighted average price of $0.80 per Share. ASEAB 36 months from the date of issue of the Performance Rights. Calculated over a consecutive 20 day period prior to the expiry date. 9,530,000 Where the Company’s share price reaches a volume weighted average price of $0.12 per Share. 953,000 Where the Company’s share price reaches a volume weighted average price of $1.20 per Share. ASEAC 36 months from the date of issue of the Performance Rights Calculated over a consecutive 30 day period prior to the expiry date. 9,530,000 Where the Company’s Share price reaches a volume weighted average price of $0.16 per Share. 953,000 Where the Company’s Share price reaches a volume weighted average price of $1.60 per Share. ASEAD 36 months from the date of issue of the Performance Rights. Calculated over a consecutive 30 day period prior to the relevant expiry date. 9,530,000 Where the Company’s Share price reaches a volume weighted average price of $0.20 per Share. 953,000 Where the Company’s Share price reaches a volume weighted average price of $2.00 per Share. ASEAS 36 months from the date of issue of the Performance Rights (ASEAS Term). Calculated over any period of 30 consecutive Trading Days: (a) during the first 18 months of the ASEAS Term for the first 5,220,000 ASEAS Performance Rights; and (b) during the ASEAS Term for the remaining 5,220,000 ASEAS Performance Rights. 10,440,000 Where the Company’s Share price reaches a volume weighted average price of: (a) $0.08 per Share for the first 5,220,000 ASEAS Performance Rights; and (b) $0.12 per Share for the remaining 5,220,000 ASEAS Performance Rights. 1,044,000 Where the Company’s Share price reaches a volume weighted average price of: (a) $0.80 per Share for the first 5,220,000 ASEAS Performance Rights; and (b) ($1.20 per Share for the remaining 5,220,000 ASEAS Performance Rights. 5.4 Fractional entitlements Not all security holders will hold that number of Securities which can be evenly divided by 10. Fractional entitlements will be rounded down to the nearest whole number. 5.5 Indicative timetable If this Resolution is passed, the Consolidation will take effect in accordance with the following timetable (as set out in Appendix 7A (paragraph 7) of the Listing Rules): 5955-01/3781790_10 11 ACTION DATE Company announces Consolidation and releases Appendix 3A.3 Wednesday, 22 October 2025 Company sends out the Notice Wednesday, 22 October 2025 Shareholders approve the Consolidation Friday, 21 November 2025 Company announces Effective Date of Consolidation Friday, 21 November 2025 Effective Date of Consolidation Friday, 21 November 2025 Last day for pre-Consolidation trading Monday, 24 November 2025 Post-Consolidation trading commences on a deferred settlement basis Tuesday, 25 November 2025 Record Date Wednesday, 26 November 2025 Last day for the Company to register transfers on a pre-Consolidation basis First day for the Company to update its register and send holding statements to security holders reflecting the change in the number of Securities they hold Thursday, 27 November 2025 Last day for the Company to update its register and to send holding statements to security holders reflecting the change in the number of Securities they hold and to notify ASX that this has occurred Wednesday, 3 December 2025 The above timetable is indicative only and the Board reserves the right to vary the timetable subject to compliance with the Listing Rules and all other applicable laws. 5.6 Holding statements From the date two Business Days after the Effective Date (as set out in the timetable in Section 5.5 above), all holding statements for Securities will cease to have any effect, except as evidence of entitlement to a certain number of Securities on a post- Consolidation basis. After the Consolidation becomes effective, the Company will arrange for new holding statements for Securities to be issued to holders of those Securities. It is the responsibility of each security holder to check the number of Securities held prior to disposal or exercise (as the case may be). 5.7 Taxation It is not considered that any taxation implications will exist for security holders arising from the Consolidation. However, security holders are advised to seek their own tax advice on the effect of the Consolidation and neither the Company, nor its advisers, accept any responsibility for the individual taxation implications arising from the Consolidation. 5955-01/3781790_10 12 G L O S S AR Y $ means Australian dollars. 7.1A Mandate has the meaning given in Section 4.1. AEDT means Eastern Daylight Time as observed in Sydney, New South Wales. ASIC means the Australian Securities & Investments Commission. ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires. Board means the current board of directors of the Company. Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day. Chair means the chair of the Meeting. Closely Related Party of a member of the Key Management Personnel means: (a) a spouse or child of the member; (b) a child of the member’s spouse; (c) a dependent of the member or the member’s spouse; (d) anyone else who is one of the member’s family and may be expected to